SCHEMBL20081302

SCHEMBL20081302

CCc1nc2ccc(F)cc2c(=O)n1-c1cccc(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.52
▸ PDE10A Q9Y233 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ TDO2 P48775 2/20 0.47
▸ IDO2 Q6ZQW0 2/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ PLA2G1B P04054 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ ATG4B Q9Y4P1 1/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ HTR7 P34969 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20081376 0.93 HPD (0.49) POLBTDO2IDO2HDAC1HDAC8
SCHEMBL16854205 0.90 HDAC1 (0.55) POLBPDE10ASMN1; SMN2ALDH1A1TDO2
SCHEMBL20081378 0.83 ALOX12 (0.53) POLBSMN1; SMN2ALDH1A1TDO2IDO2
SCHEMBL22238128 0.82 USP2 (0.59) PDE10ASMN1; SMN2ALDH1A1L3MBTL1USP2
SCHEMBL20081323 0.79 PIK3CD (0.51) POLBPDE10ASMN1; SMN2ALDH1A1LMNA
SCHEMBL18332822 0.78 POLB (0.65) POLBSMN1; SMN2ALDH1A1TSHRHTT
SCHEMBL20404407 0.77 ESR1 (0.44) SMN1; SMN2ALDH1A1USP2
SCHEMBL22237904 0.77 PIK3CD (0.50) SMN1; SMN2ALDH1A1USP2
SCHEMBL20081212 0.77 PDE10A (0.47) PDE10ASMN1; SMN2LMNAMEN1PLA2G1B
SCHEMBL15819051 0.76 HTR7 (0.45) PDE10AALDH1A1TDO2IDO2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312175-B1 HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT KOREA RES INST CHEMICAL TECH (KR) 2020-07-22 — — EP disclosed
EP-3312175-A1 HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2018-04-25 — — EP disclosed
Send feedback